Text Box: Newsletter
Abreast Of  Ear, Nose & Throat / Head & Neck Advances
9,March,  2006
 
Hello, All. Welcome to this week's ORL Update. I spent the entire day receiving birthday wishes that I almost forgot the newsletter is almost belated by 5 days! I do hope you find the pick for this edition useful
 
Biodun Olusesi, Newsletter Editor
OME and COX-2.......?

The quest to probe the causative factors in OME was taken to the next dimension recently when attempts were made to investigate the relationship between the cyclooxygenase-2 enzyme  - known to catalyze the synthesis of prostaglandins - and serous otitis media. Masachi Kakiuchi et al (American Journal of Otolaryngology–Head and Neck Medicine and Surgery 27 (2006) 81– 85) studied COX-2 expression in experimental mice OME models and concluded that COX-2 may be a contributing factor in pathogenesis of OME, with an implication for future role of COX-2 inhibitors in management of OME.

Abstract: Objectives: To study whether cyclooxygenase 2 (COX-2) plays a role in the development of otitis media with effusion (OME). Study design/methods: An experimental model of endotoxin-induced OME was used in healthy BALB/c mice. Solutions of Salmonella typhimurium endotoxin were injected into the middle ears of the mice, and COX-2 expression in the middle ears was studied using reverse transcription– polymerase chain reaction (RT-PCR) and in situ hybridization (ISH). Results: Analysis by RT-PCR showed that COX-2 expression in the middle ear increased in a dosedependent fashion after injection of endotoxin. ISH demonstrated that COX-2 had distinct expression patterns in the epithelium of middle ears with endotoxin-induced OME. COX-2 expression, however, was not detected in normal middle ears. Conclusions: COX-2 expression may be one factor contributing to the development of OME.
 
TOP PICKS

Sentinel Lymph Node Biopsy & Superficial Oesophageal Cancer..?
Since its popularization in the management of head and neck melanomas in early 1990s, the use of SLNB has been gaining wide acceptance as a staging modality in several head and neck malignancies. Hayashi H. et al recently (Surgery. 2006 Feb;139(2):224-35)  experimentally and clinically the evaluated the feasibility of endoscopic CT Lymphography in superficial oesophageal cancer and concluded it has potential in SLNB and mapping of oesophageal lesion.

Abstract: BACKGROUND: To evaluate experimentally and clinically the feasibility of a newly developed technique of endoscopic computed tomography (CT) lymphography with endoscopic submucosal injection of iopamidol for esophageal sentinel lymph node (SLN) mapping and biopsy examination. METHODS: Nine anesthetized dogs underwent CT after endoscopic submucosal injection of 2 mL iopamidol; 1.25-mm thick CT images were obtained before and at 1, 3, 5, 7, and 10 minutes after contrast injection. Clinically, 12 patients with superficial esophageal cancer (preoperative imaging stage: cT1, cN0) underwent CT lymphography in a similar fashion at 1, 5, and 10 minutes after peritumoral injection, followed by radical esophagectomy and regional lymph node dissection under CT lymphography guidance. RESULTS: CT lymphography visualized the draining lymphatic vessels and SLNs within 5 minutes after contrast injection. All 14 SLNs in dogs (average, 1.5 nodes per animal; range, 1-2) and 28 SLNs in patients (average, 2.3 nodes per patient; range, 1-4) were found intraoperatively at the correct location under CT lymphography guidance. Lymph node metastasis could be detected with excellent sensitivity and accuracy in this small number of patients with no false-negative findings; metastasis was positive only in the preoperatively identified SLNs in 4 patients and in both SLNs and distant nodes in 1 patient, and was negative in all resected nodes in the remaining 7 patients. CONCLUSIONS: Endoscopic CT lymphography appears to allow accurate identification of direction and locations of lymph flow and SLNs, and has the potential clinical applicability for esophageal SLN mapping and biopsy examination, but will require a large study to determine its accuracy and usefulness


Coming Events of Importance to Otolaryngologists in Africa...
 

  1. 8th International Otology Course of the Jean Causse Ear Clinic
    June 22-24, 2006; Béziers, France
  2. 110th American Academy of ORL,Head & Neck Surgery Annual Meeting & OTO EXPO
    September 17-20, 2006;
    Toronto, Canada.
  3. 42nd South African ENT Congress joint meeting with the British Association of Otolaryngology - Head & Neck Surgery
    October 29-November 1, 2006;
    Cape Town, South Africa.

         For more Worldwide otolaryngological events and conferences....Click Here


Horizontal Canal BPPV - How Common.....?       

A recent retrospective study, with Evidence Based Medicine rating of 4,  from Turkey (Cakir BO et al, Otolaryngol Head Neck Surg. 2006 Mar;134(3):451-454) examined the record of 169 patients managed for BPPV over a 4 year period and discovered that horizontal canal BPPV (H-BPPV) constitutes over 10%

Abstract: OBJECTIVE: To assess the correct incidence of horizontal semicircular canal (H-SCC) benign paroxysmal positional vertigo (BPPV). STUDY DESIGN: Retrospective assessment of patients with BPPV. METHODS: All patients with BPPV were included and the rates of involvement of posterior, horizontal, and anterior SCCs were determined. RESULTS: One hundred sixty-nine patients with the diagnosis of BPPV were evaluated. One hundred forty-four patients (85.2%) were found to have posterior SCC (P-SCC) involvement, and there were 20 patients (11.8%) with horizontal SCC (H-SCC) and 2 patients (1.2%) with anterior SCC (A-SCC) involvement. Three patients (1.8%) had simultaneous H-SCC and P-SCC BPPV ipsilaterally. Geotropic nystagmus was seen in 17 out of 23 patients (73.9%) in roll test, and ageotropic nystagmus was seen in the remaining 6 patients (26.1%). CONCLUSION: H-SCC constitutes 13.6% of all BPPV cases. H-SCC BPPV with geotropic nystagmus is more common. H-SCC BPPV can coexist with ipsilateral P-SCC BPPV. However, in some cases of H-SCC BPPV, Dix-Hallpike maneuver can cause vertigo and horizontal nystagmus. This may be confused with P-SCC BPPV. Therefore, the roll test must be performed in all cases in addition to Dix-Hallpike maneuver and both ears must be evaluated with respect to all SCCs for BPPV

Text Box: Previous Newsletter

 
Case Review
 
CLINICAL AUDIOGRAM  OF THE WEEK

A 23-year old female presented with progressive bilateral hearing impairment of . 3 months duration. She denied any previous head/ear trauma, otorrhoea exposure to loud noise, or preceding ingestion of known ototoxic drugs. There was negative family history of hearing impairment. Clinical examination including otoscopy was not remarkable. Her left ear pure tone audiogram is shown in this picture. You may want to View audiogram for both ears for clarity.

 

What is the diagnosis?

  • Parting Shot...
    If you have an interesting case to discuss or share with other Otolaryngologists all over Africa, feel free to email Me or at best go to otolaryngology in Africa blogsite and post your case
  • Also, if you are among those who requested for a copy of DODA at the last ORLSON Meeting @ Port Harcourt, please take time to view the DODA - FAQ page, you should have received your copy by now. If you have difficulty on using the program, please text +2348032472069.
  • An online video demonstration of doda is available at http://www.otolaryngologyinafrica.net/doda_video.htm  This video takes about 30 - 45 minutes to fully load on a broad band network the first time, but once fully loaded could be viewed over and over again
  • If you have anything you want to communicate with other Otolaryngologists - news, request, etc, feel free to email your communication to orl-mailer@ otolaryngologyinafrica.net. Your request will appear in member's page soon to be created.
  • Reviewers wanted for otolaryngology news journals watch page. If you are an Otolaryngologist in Africa and will like to be our journal reviewer, please feel free to email orl-mailer@otolaryngologyinafrica.net

Till Next Week,

Biodun


 

NEWSLETTER                    TOP                  PREVIOUS NEWSLETTER

This is a free email newsletter circulating to Otolaryngologists in Africa, and interested Otolaryngologists elsewhere. If you know anyone interested in receiving this free newsletter, feel free to forward a copy to such person or encourage them to email orl-mailer@otolaryngologyinafrica.net for subscription

© Copyright Dr 'Biodun Olusesi,  2005 - 2006

Embedded CGI removed by Open WebMail.
http://www.processrequest.com/apps/msgopen.asp?id=23671813,ZddihibaheEB&oid=UcjjbCB&taskid=WhjjfjjEI

 
Text Box: Vol.2, No.8, March, 2006

Text Box: Home